Katerina Antoniou (Heraklion, Crete, Greece), Francesco Bonella (Dusseldorf, Germany)
Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians
Ivan Cherrez Ojeda (Guayaquil, Ecuador), Ivan Cherrez Ojeda, Vincent Cottin, Juan Calderon, Erick Calero, Dayana Cabrera, Annia Cherrez, Jose Martin Vilema
|  |
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Maria Kontou (Athens, Greece), Maria Kontou, Velissaria Bousgou, Vasileios Tzilas, Evangelos Bouros, Stamatios Tsipilis, Anreas Granitsas, Evangelos Marozanes, George Dionelis, Nikolaos Koulouris, Demosthenes Bouros
|  |
The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Monika Žurková (Olomouc, Czech Republic), Monika Zurková, Vítezslav Kolek, Vladimíra Loštáková, Eva Kriegová, Martina Šterclová, Vladimír Bartoš, Martina Doubková, Ilona Binková, Michal Svoboda, Jana Strenková, Martina Placková, Ladislav Lacina, Vladimir Rihak, František Petrík, Pavlína Lisá, Radka Bittenglová, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Pšikalová, Tomáš Snízek, Jirí Homolka, Renata Králova, Jan Kervitzer, Martina Vašáková
| |
Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Katleen Leceuvre (Kessel-lo, Belgium), Katleen Leceuvre, Els De Dycker, Tom Moerman, Jonas Yserbyt, Wim Wuyts
| |
Long-term safety of combination therapy with nintedanib and pirfenidone in Japanese patients with IPF
Hiroyuki Taniguchi (Nisshin, Japan), Hiroyuki Taniguchi, Takashi Ogura, Yoshikazu Inoue, Manabu Akimoto, Arata Azuma
| |
Nintedanib for idiopathic pulmonary fibrosis (IPF): Data from the German compassionate use program (CUP)
Francesco Bonella (Dusseldorf, Germany), Francesco Bonella, Michael Kreuter, Lars Hagmeyer, Claus Neurohr, Claus Keller, Martin J. Kohlhäufl, Joachim Müller-Quernheim, Katrin Milger, Antje Prasse
| |
Effect of pirfenidone on IPF progression
Ginevra Del Giudice (Benevento, Italy), Diana Radicella, Ginevra Del Giudice, Assunta Micco, Mariano Mazza, Mario Del Donno
| |
Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
Sojung Park (Seoul, Republic of Korea), Sojung Park, Jisun Lee, Dong Soon Kim, Jin Woo Song
| |
Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis
Eva Brunnemer (Heidelberg, Germany), Eva Brunnemer, Svenja Ehlers-Tenenbaum, Calus Peter Heussel, Arne Warth, Felix Herth, Michael Kreuter
| |
MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages
Katerina Antoniou (Heraklion, Crete, Greece), Eliza Tsitoura, Athol U. Wells, Chara Koutoulaki, Konstantinos Karagiannis, Ismini Lasithiotaki, Eirini Vasarmidi, Hiroe Sato, Demetrios A. Spandidos, Nikolaos M. Siafakas, Georgios Sourvinos, Katerina Antoniou
| |
Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung
Kaustav Chakraborty (Kolkata, India), Kaustav Chakraborty, Arindam Bhattacharyya
| |
Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis
Hiroyuki Taniguchi (Nisshin, Japan), Hiroyuki Taniguchi, Yasuhiro Kondoh, Taiki Furukawa, Tomoki Kimura, Kensuke Kataoka, Takeshi Johkoh, Junya Fukuoka, Keiko Hasegawa
| |
Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis?
Radwa Elhefny (Cairo, Egypt), Radwa Elhefny, Sabah Ahmed, Marwa Moawad, Mona Abdullatif
| |
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Hirotsugu Ohkubo (Nagoya, Japan), Hirotsugu Ohkubo, Mitsuaki Yagi, Yasuhiro Kondoh, Takeshi Johkoh, Hiroaki Arakawa, Akio Niimi, Hiroyuki Taniguchi
| |
First insights from the BTS idiopathic pulmonary fibrosis (IPF) registry
Monica Spiteri (Stoke-on-Trent, United Kingdom), Monica Spiteri, William Chang, Nazia Chaudhuri, Robina K. Coker, Sue Copley, Owen Dempsey, Ian Forrest, Michael Gibbons, Ling-Pei Ho, Toby M. Maher, Helen Parfrey, Luca Richeldi, Lisa Spencer
| |
Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry
Helen Jo (Sydney, Australia), Helen Jo, Ian Glaspole, Yuben Moodley, Sally Chapman, Wendy Cooper, Samantha Ellis, Nicole Goh, Peter Hopkins, Greg Keir, Annabelle Mahar, Paul Reynolds, Haydn Walters, Christopher Zappala, Christopher Grainge, Heather Allan, Tamera Corte
| |
Survival from acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with polymyxin B-immobilized fiber column: A retrospective analysis
Keiji Oishi (Yamaguchi, Japan), Keiji Oishi, Keisuke Aoe, Yusuke Mimura, Yoriyuki Murata, Kenji Sakamoto, Wataru Koutoku, Tsuneo Matsumoto, Hiroshi Ueoka, Kazuto Mastunaga, Masafumi Yano
| |
A supportive care decision aid tool for idiopathic pulmonary fibrosis
Charles Sharp (Bristol, United Kingdom), Charles Sharp, Adrienne Edwards, Heather Lamb, Sorayya Alam, Nikki Jordan, Rachel Gunary, Patricia Meek, Ann Millar, Clare Kendall, Huzaifa Adamali
| |